期刊文献+

血小板线粒体代谢异常与高同型半胱氨酸血症相关动脉血栓性疾病研究现状和展望 被引量:1

Current Understanding and Perspectives of Platelet Mitochondrial Metabolism Dysfunction and Diseases Based on Hyperhomocysteinemia-related Arterial Thrombosis
原文传递
导出
摘要 高同型半胱氨酸血症(hyperhomocysteinemia,HHcy)与冠状动脉或脑循环动脉血栓等心脑血管疾病的发生密切相关。血小板功能异常在动脉血栓形成中发挥关键作用。已知HHcy与血小板激活、凋亡等功能异常关系密切。血小板线粒体代谢调控是目前血小板研究领域的新热点。本文对HHcy调控血小板线粒体代谢与血小板功能关系的研究进展进行评述,深入了解血小板线粒体在血小板功能异常及其在动脉血栓形成中的作用,并提出新的防治策略。 Hyperhomocysteinemia(HHcy)is closely related to the occurrence of cardiovascular and cerebrovascular diseases such as coronary or cerebral arterial thrombosis.Platelet disfunction plays a key role in arterial thrombosis.It is known that HHcy is closely related to platelet activation and apoptosis.The regulation of platelet mitochondrial metabolism is a new area in platelet research.This article reviews the research progress of the relationship between platelet mitochondrial metabolism and function in HHcy,which is helpful to deepen the understanding of platelet mitochondria in platelet dysfunction and its role in arterial thrombosis,and propose new prevention and treatment strategies.
作者 韩露露 冯娟 王宪 HAN Lu-lu;FENG Juan;WANG Xian(Department of Physiology and Pathophysiology,School of Basic Medical Sciences,Peking University&Key Laboratory of Molecular Cardiovascular Science,Ministry of Education,Beijing 100191,China)
出处 《中国分子心脏病学杂志》 CAS 2020年第4期3433-3436,共4页 Molecular Cardiology of China
基金 国家自然科学基金(91739303)。
关键词 高同型半胱氨酸血症 血小板 线粒体 代谢应激 Hyperhomocysteinemia Platelet Mitochondrial Metabolism stress
  • 相关文献

参考文献3

二级参考文献27

  • 1Jobe SM, Wilson KM, Leo L, et al. Critical role for the mitochondrial permeability transition pore and cyclo- philin-D in platelet activation and thrombosis. Blood, 2008,111(3): 1257-1265.
  • 2Remenyi G, Szasz R, Friese P, et al. Role of mitochon- drial permeability transition pore in coated-platelet forma- tion. Arterioscler Thromb Vasc Biol, 2005,25(2):467-471.
  • 3Liu F, Gamez G, Myers DR, et al. Mitochondrially medi- ated integrin alpha(II b)beta(3) protein inactivation limits thrombus growth. J Biol Chemist, 2013,288(42):30 672- 30 681.
  • 4Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med, 2000,6(5):513-519.
  • 5Qiao S, Olson JM, Paterson M, et al. MicroRNA-21 me- diates isoflurane-induced cardioprotection against ische- mia-reperfusion injury via Akt/Nitric oxide syn- thase/mitochondrial permeability transition pore pathway. Anesthesiology, 2015 Aug 7. [Epub ahead of print].
  • 6Liu G, Wang ZK, Wang ZY, et al. Mitochondrial perme- ability transition and its regulatory components are impli- cated in apoptosis of primary cultures of rat proximal tu- bular cells exposed to lead. Arch Toxicol, 2015 June 17. [Epub ahead of print].
  • 7Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol, 2003,23(12): 2131-2137.
  • 8Maione F, Cicala C, Liverani E, et al. IL-17A increases ADP-induced platelet aggregation. Bioc Biop Res Com- mun, 2011,408(4):658-662.
  • 9Zhang S, Yuan J, Yu M, et al. IL-17A facilitates platelet function through the ERK2 signaling pathway in patients with acute coronary syndrome. Plos One, 2012,7(e406417).
  • 10Leytin V, Allen D J, Mutlu A, et al. Mitochondrial control of platelet apoptosis: effect of cyclosporine-A, an inhibitor of the mitochondrial permeability transition pore. Lab In-vest, 2009,89(4):374-384.

共引文献20

同被引文献19

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部